Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.635
-0.015 (-2.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $79.57 million as of December 20, 2024. Its market cap has decreased by -17.20% in one year.
Market Cap
79.57M
Enterprise Value
213.81M
1-Year Change
-17.20%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $79.57M, a decrease of -82.03%. That is a compound annual growth rate of -14.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 79.60M | -19.68% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 84.00M |
| EDAP TMS | 83.74M |
| Tiziana Life Sciences | 83.54M |
| 23andMe Holding Co. | 83.19M |
| OS Therapies | 83.04M |
| bluebird bio | 81.87M |
| Entera Bio | 79.56M |
| Adlai Nortye | 78.97M |